Literatur
- 1
Aggarwal S, Pittenger M F.
Human mesenchymal stem cells modulate allogeneic immune cell responses.
Blood.
2005;
105
1815-1822
- 2
Devine S M, Cobbs C, Jennings M, Bartholomew A, Hoffman R.
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion
into nonhuman primates.
Blood.
2003;
101
2999-3001
- 3
Djouad F, Fritz V, Apparailly F. et al .
Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis
factor alpha in collagen-induced arthritis.
Arthritis Rheum.
2005;
52
1595-1603
- 4
Djouad F, Plence P, Bony C. et al .
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic
animals.
Blood.
2003;
102
3837-3844
- 5
Fouillard L, Bensidhoum M, Bories D. et al .
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with
severe idiopathic aplastic anemia improves stroma.
Leukemia.
2003;
17
474-476
- 6
Frassoni F, Labopin M, Bacigalupo A.
Expanded mesenchymal stem cells (MSC), co-infused with HLA-identical hematopoietic
stem cell transplants, reduce acute and chronic graft-versus-host disease: a matched
pair analysis (abstract 75).
Bone Marrow Transplant.
2002;
(suppl 2)
29
S2
- 7
Horwitz E M, Gordon P L, Koo W K. et al .
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth
in children with osteogenesis imperfecta: Implications for cell therapy of bone.
Proc Natl Acad Sci U S A.
2002;
99
8932-8937
- 8
Ishida T, Inaba M, Hisha H. et al .
Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic
bone marrow transplantation.
J Immunol.
1994;
152
3119-3127
- 9
Jorgensen C, Djouad F, Fritz V, Apparailly F, Plence P, Noel D.
Mesenchymal stem cells and rheumatoid arthritis.
Joint Bone Spine.
2003;
70
483-485
- 10
Koc O N, Day J, Nieder M. et al .
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy
(MLD) and Hurler syndrome (MPS-IH).
Bone Marrow Transplant.
2002;
30
215-222
- 11
Koc O N, Gerson S L, Cooper B W. et al .
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded
marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose
chemotherapy.
J Clin Oncol.
2000;
18
307-316
- 12
Le Blanc K, Gotherstrom C, Ringden O. et al .
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in
a patient with severe osteogenesis imperfecta.
Transplantation.
2005;
79
1607-1614
- 13
Le Blanc K, Rasmusson I, Sundberg B. et al .
Treatment of severe acute graft-versus-host disease with third partly haploidentical
mesenchymal stem cells.
Lancet.
2004;
363
1439-1441
- 14
Le Blanc K, Ringden O.
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem
cell transplantation.
Biol Blood Marrow Transplant.
2005;
11
321-334
- 15
Wagner W, Wein F, Seckinger A. et al .
Comparative characterization of mesenchymal stem cells from human bone marrow, adipose
tissue and umbilical cord blood.
Exp Hematol.
2005;
33
1402-1416
- 16
Lazarus H M. et al .
Ex vivo expansion and subsequent infusion of human bone-marrow-derived stromal progenitor
cells (mesenchymal progenitor cells): implications for therapeutic use.
Bone Marrow Transplantation.
1995;
16
557
Prof. Dr. Hanns-Martin Lorenz
Sektion Rheumatologie, Medizinische Klinik V, Universität Heidelberg
Im Neuenheimer Feld 410
69120 Heidelberg
Telefon: 06221-568044
Fax: 06221-566824
eMail: hannes.lorenz@med.uni-heidelberg.de
